Crescentic glomerulonephritis associated with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia

被引：17
|
作者：
Tisler, A
Pierratos, A
Lipton, JH
机构：
[1] UNIV TORONTO,WELLESLEY HOSP,DIV NEPHROL,TORONTO,ON M5S 1A1,CANADA
[2] SEMMELWEIS UNIV MED,DEPT MED 1,H-1085 BUDAPEST,HUNGARY
[3] UNIV TORONTO,PRINCESS MARGARET HOSP,DEPT MED,TORONTO,ON M5S 1A1,CANADA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1996年 / 11卷 / 11期
关键词：
chronic lymphocytic leukaemia; crescentic glomerulonephritis; fludarabine; perinuclear antineutrophil cytoplasmic antibodies;
D O I：
10.1093/oxfordjournals.ndt.a027155
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：2306 / 2308
页数：3
相关论文
共 50 条
  • [21] Phase II, Single Center Study of Oral Forodesine in Patients with Advanced, Fludarabine-Treated Chronic Lymphocytic Leukemia (CLL)
    Verma, Dushyant
    Balakrishnan, Kumudha
    O'Brien, Susan
    Thomas, Deborah A.
    Ferrajoli, Alessandra
    Wierda, William G.
    Verma, Amit
    Faderl, Stefan
    Bickel, Susan M.
    Bantia, Shanta
    Kantarjian, Hagop M.
    Keating, Michael J.
    Gandhi, Varsha
    Ravandi, Farhad
    BLOOD, 2009, 114 (22) : 935 - 936
  • [22] P-ANCA AND ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY POSITIVE GLOMERULONEPHRITIS IN CHRONIC COCAINE USERS
    Flores, Edeliz
    Bilal, Mum
    Monrroy, Mauricio
    Chaudhry, Rafia
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 69 (04) : A43 - A43
  • [23] P53 deletion and fludarabine-resistance in chronic lymphocytic leukaemia.
    Bowen, AL
    Bosanquet, AG
    Catovsky, D
    Matutes, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 85 - 85
  • [24] Low-dose fludarabine in chronic lymphocytic leukaemia associated membranous glomerulopathy.
    Zachee, PPGBJ
    Vanrenterghem, YY
    Van Damme, BB
    Monballyu, JJ
    Delforge, MM
    BLOOD, 2002, 100 (11) : 360B - 360B
  • [25] Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab - incidence and predictors
    Borthakur, Gautam
    O'Brien, Susan
    Wierda, William G.
    Thomas, Deborah A.
    Cortes, Jorge E.
    Giles, Francis J.
    Kantarjian, Hagop M.
    Lerner, Susan
    Keating, Michael J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (06) : 800 - 805
  • [26] Chronic Lymphocytic Leukaemia Associated with Paraneoplastic MPO-ANCA Positive Microscopic Polyangiitis
    Hubel, K.
    Hitz, F.
    Koneth, I.
    Binet, I.
    SWISS MEDICAL WEEKLY, 2011, 141 : 19S - 19S
  • [27] A case of Sweet's syndrome associated with monoclonal immunoglobulin of IgG-lambda type and p-ANCA positivity
    Nocente, R
    Cammarota, G
    Silveri, NG
    Rotoli, M
    Zannoni, GF
    Bertazzoni, G
    Ceccanti, M
    Gasbarrini, G
    PANMINERVA MEDICA, 2002, 44 (02) : 149 - 150
  • [28] Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial
    Elter, Thomas
    Gercheva-Kyuchukova, Liana
    Pylylpenko, Halyna
    Robak, Tadesuz
    Jaksic, Branimir
    Rekhtman, Grigoriy
    Kyrcz-Krzemien, Slawomira
    Vatutin, Mykola
    Wu, Jingyang
    Sirard, Cynthia
    Hallek, Michael
    Engert, Andreas
    LANCET ONCOLOGY, 2011, 12 (13): : 1204 - 1213
  • [29] A Rare Case of Crescentic Glomerulonephritis, Diffuse Proliferative Class IV Lupus Nephritis, and Collapsing Glomerulopathy in a COVID, P-ANCA, and Myeloperoxidase-Positive Patient
    Ganglam, Ajay B.
    Batool, Fatima
    Miick, Ronald
    Chewaproug, Daranee
    Pedroza, Mauricio A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 505 - 505
  • [30] Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine
    Alexopoulou, Alexandra
    Dourakis, Spyros P.
    Pandelidaki, Helen
    Archimandritis, Athanasios J.
    Karayiannis, Peter
    JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (08) : 1043 - 1046
12345